ClinicalTrials.Veeva

Menu

miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB)

University Hospital Basel logo

University Hospital Basel

Status

Withdrawn

Conditions

Active Tuberculosis

Treatments

Diagnostic Test: Next Generation Sequencing

Study type

Observational

Funder types

Other

Identifiers

NCT05048381
2021-01810 am21Eckstein2;

Details and patient eligibility

About

The detection of miRNA (non-coding ribonucleic acid) in the blood in the context of active tuberculosis is an innovative approach to the detection of new disease-specific biomarkers.

The primary goal of this analysis is to define, for the first time, an miRNA fingerprint for tuberculosis in sweat. Samples that were collected as part of the Sweatb Study (NCT03667742) project are examined for the occurrence of disease-specific, non-coding miRNAs to define new biomarkers in the sweat. These biomarkers can be detected non-invasively and will help in the detection of patients with active tuberculosis.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients
  • Ability to understand the purpose of the study, provide signed and dated informed consent by patient or his/her legal representative
  • In-patients with acute tuberculosis, suspected tuberculosis or other pulmonary diseases (pneumonia, Bronchitis, COPD)

Inclusion criteria Healthy Donors:

  • negative for Quantiferon- TB Gold Plus Test or ELISpot

Exclusion criteria

  • Written rejection of the consent for the further use of the data

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems